Ray Dalio's TXG Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 177,734 shares of 10x Genomics, Inc. (TXG) worth $2.9 M, representing 0.01% of the portfolio. First purchased in 2021-Q3, this short-term holding has been held for 8 quarters.
Based on 13F filings, Ray Dalio has maintained this position in TXG for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 177,734 shares. Largest reduction occurred in Q1 2023, reducing 13,044 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +177,734 | New Buy | 177,734 | $16.31 |
| Q1 2023 | -13,044 | Sold Out | 0 | $0.00 |
| Q4 2022 | +13,044 | New Buy | 13,044 | $36.44 |
| Q3 2022 | -8,676 | Sold Out | 0 | $0.00 |
| Q2 2022 | +2,494 | Add 40.34% | 8,676 | $45.30 |
| Q1 2022 | +6,182 | New Buy | 6,182 | $76.03 |
| Q4 2021 | -1,988 | Sold Out | 0 | $0.00 |
| Q3 2021 | +1,988 | New Buy | 1,988 | $145.37 |
Ray Dalio's 10x Genomics Investment FAQs
Ray Dalio first purchased 10x Genomics, Inc. (TXG) in Q3 2021, acquiring 1,988 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held 10x Genomics, Inc. (TXG) for 8 quarters since Q3 2021.
Ray Dalio's largest addition to 10x Genomics, Inc. (TXG) was in Q4 2025, adding 177,734 shares worth $2.9 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 177,734 shares of 10x Genomics, Inc. (TXG), valued at approximately $2.9 M.
As of the Q4 2025 filing, 10x Genomics, Inc. (TXG) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in 10x Genomics, Inc. (TXG) was 177,734 shares, as reported at the end of Q4 2025.